Fingerprint
Dive into the research topics of 'Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage
Hwa Jung Sung, Se Ryeon Lee, In Keun Choi, Yong Park, Chul Won Choi, Hyeoung Joon Kim, Ho Young Yhim, Byung Soo Kim
Research output: Contribution to journal › Article › peer-review
5
Citations
(Scopus)